Recon: Sen. Manchin opposes Woodcock for FDA Commissioner; BMS, Eisai in $3.1B cancer drug development deal

ReconReconBiologicsBiotechnologyCombination ProductsDiagnosticsMedical DevicesPharmaceuticals